Logo-bi
Hypothesis

1. Stem cell therapy of cataract
Masoud Maleki*
Bioimpacts. 2015;5(4): 165-167. doi: 10.15171/bi.2015.24
PMCID: PMC4769785     PMID: 26929919     Scopus ID: 84958160169    
Article
PDF
XML
Cited By:
4
0
4
Editorial

2. Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(2): 65-69. doi: 10.15171/bi.2015.18
PMCID: PMC4492186     PMID: 26191499     Scopus ID: 84930410369    
Article
PDF
XML
Cited By:
3
0
2
Original Research

3. A rapid sonication based method for preparation of stromal vascular fraction and mesenchymal stem cells from fat tissue
Mohammad Amir Amirkhani, Rashin Mohseni, Masoud Soleimani, Alireza Shoae-Hassani, Mohammad Ali Nilforoushzadeh*
Bioimpacts. 2016;6(2): 99-104. doi: 10.15171/bi.2016.14
PMCID: PMC4981255     PMID: 27525227     Scopus ID: 84983507799    
Article
PDF
Full Text
XML
Cited By:
18
6
16
Editorial

4. Hydrogels for ocular drug delivery and tissue engineering

Marzieh Fathi, Jaleh Barar ORCID, Ayuob Aghanejad, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(4): 159-164. doi: 10.15171/bi.2015.31
PMCID: PMC4769784     PMID: 26929918     Scopus ID: 84958155033    
Article
PDF
XML
Cited By:
59
16
55
Original Research

5. Rejuvenation of facial skin and improvement in the dermal architecture by transplantation of autologous stromal vascular fraction: a clinical study
Mohammad Amir Amirkhani, Alireza Shoae-Hassani, Masoud Soleimani, Somayeh Hejazi, Leila Ghalichi, Mohammad Ali Nilforoushzadeh*
Bioimpacts. 2016;6(3): 149-154. doi: 10.15171/bi.2016.21
PMCID: PMC5108987     PMID: 27853678     Scopus ID: 85003905043    
Article
PDF
Full Text
XML
Cited By:
31
4
26
Review

6. Gene and Stem Cell Therapy: Alone or in Combination?
Mohammad A. Rafi*
Bioimpacts. 2011;1(4): 213-218. doi: 10.5681/bi.2011.030
PMCID: PMC3648974     PMID: 23678430     Scopus ID: 84876718825    
Article
PDF
XML
Cited By:
17
10
0
Original Research

7. A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product
Stephan Born*, Max Johannes Dörfel, Philip Hartjen, Seyed Ali Haschemi Yekani, Julia Luecke, Juliane Katharina Meutsch, Julie Katharina Westphal, Moritz Birkelbach, Robert Köhnke, Ralf Smeets, Michael Krueger
Bioimpacts. 2019;9(3): 161-172. doi: 10.15171/bi.2019.20
PMCID: PMC6726751     PMID: 31508331     Scopus ID: 85071165666    
Article
PDF
Full Text
XML
Cited By:
4
3
3
The purification process for stromal vascular fraction (SVF) can be performed using additional short plastic adherence incubation step (16-20h). This process leads in 24h to a predictable GMP-compliant cell-product. This product is more homogenous than the SVF.
Original Research

8. Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up period

Nadezhda V. Maksimova ORCID, Anna V. Michenko, Olga A. Krasilnikova ORCID, Ilya D. Klabukov* ORCID, Igor Yu. Gadaev ORCID, Michael E. Krasheninnikov ORCID, Pavel A. Belkov, Aleksey V. Lyundup ORCID
Bioimpacts. 2022;12(1): 51-55. doi: 10.34172/bi.2021.22167
PMCID: PMC8783077     PMID: 35087716     Scopus ID: 85127152579    
Article
PDF
Full Text
XML
Cited By:
13
7
6
Three-year follow-up of patients, treated for diabetic foot ulcers with mesenchymal stromal cells that revealed absence of ulcer recurrence, neoplasms, and scar contracture. Collagen ultrasound density decreased by 57% and the epidermal thickness increased by 72% in the area of healed ulcers.
Review

9. Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics

Maryam Sayahinouri ORCID, Sahar Mashayekhi Firouz ORCID, Amin Ebrahimi Sadrabadi ORCID, Mina Masoudnia ORCID, Mahnaz Abdolahi ORCID, Fatemeh Jafarzadeh ORCID, Meshkat Nouripour ORCID, Sana Mirzazadeh ORCID, Nazanin Zangeneh ORCID, Arsalan Jalili* ORCID, Nasser Aghdami ORCID
Bioimpacts. 2023;13(2): 159-179. doi: 10.34172/bi.2023.23839
PMCID: PMC10182441     PMID: 37193075     Scopus ID: 85152105286    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
0
0
0
In COVID-19 infection, the various functions of immune cells lead to defense or failure against the virus. Cell therapy is of great importance as a new treatment for COVID-19 infection. Therefore, in this review, we have dealt with the function of immune cells against the SARS-Cov-2 virus and new treatment methods for this disease with the help of different cell types
Original Article

10. Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model
Zeinab Ghazvinian ORCID, Shahrokh Abdolahi, Mohammad Ahmadvand, Amir Hossein Emami, Samad Muhammadnejad, Hamid Asadzadeh Aghdaei, Jafar Ai, Mohammad Reza Zali, Iman Seyhoun, Javad Verdi* ORCID, Kaveh Baghaei* ORCID
Bioimpacts. 2023;13(5): 383-392. doi: 10.34172/bi.2022.26386
PMCID: PMC10509737     PMID: 37736341    
Article
PDF
Full Text
XML
Cited By:
2
0
1
Review

11. The application, safety, and future of ex vivo immune cell therapies and prognosis in different malignancies
Katelyn R. Einloth ORCID, Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden* ORCID
Bioimpacts. 2023;13(6): 439-455. doi: 10.34172/bi.2023.27521
PMCID: PMC10676524     PMID: 38022382    
Article
PDF
Full Text
XML
Cited By:
1
0
0
Review

12. Regulation of cell fate by cell imprinting approach in vitro
Farkhonde Hasannejad ORCID, Leila Montazeri, João F Mano* ORCID, Shahin Bonakdar* ORCID, Ahmad ‎ Fazilat
Bioimpacts. 2024;14(3): 29945. doi: 10.34172/bi.2023.29945
Article
PDF
XML
Cited By:
0
0
0
Original Article

13. Burn wound healing using adipose-derived mesenchymal stem cells and manganese nanoparticles in polycaprolactone/gelatin electrospun nanofibers in rats
Azin Shahmohammadi ORCID, Hadi Samadian, Saeed Heidari Keshel, Khodabakhsh Rashidi, Amir Kiani, Masoud Soleimani*, Farjam Goudarzi* ORCID
Bioimpacts. 2024;. doi: 10.34172/bi.2024.30193
Article
PDF
Suppl 1
XML
Cited By:

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge